Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7P59 refers to a pseudogene related to the ribosomal protein L7 gene and does not encode a functional protein. Pseudogenes like RPL7P59 result from gene duplication or retrotransposition events; they share sequence similarity with functional genes but typically lack protein-coding ability or regulatory roles. There is no evidence that RPL7P59 has a functional or druggable role in disease or therapeutics. Its existence is mainly of genomic and evolutionary interest as part of the large family of ribosomal protein pseudogenes dispersed throughout the human genome[2][3][4][9]. Summary and context: RPL7P59 is a processed pseudogene and not a coding gene, enzyme, receptor, transporter, or therapeutic target. It can be distinguished from the functional gene RPL7, which encodes the ribosomal protein L7 involved in ribosome structure and function[1][5][6][7]. RPL7P59 itself does not contribute directly to biological processes or disease mechanisms[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 59 (RPL7P59).